Observational Study
researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease.
CureGN
Cure Glomerulonephropathy Network
Brief Description
Cure Glomerulonephropathy (CureGN) is a multicenter five-year observational study of glomerular disease patients.
Trial Physician / Study Coordinator
Sherry Wilson
Email PhoneSite Name
Riley Children's Hospital
699 Riley Hospital Drive
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Observational Study
researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease.
CureGN
Cure Glomerulonephropathy Network
Brief Description
Cure Glomerulonephropathy (CureGN) is a multicenter five-year observational study of glomerular disease patients.
Trial is for people with
Primary focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), and IgA nephropathy (IgAN)
Study Goal
The CureGN project will study 2,400 children and adults with the following glomerular diseases: minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IgAN).
What is involved for the Patient?
Participants' health will be monitored over 5 years. This may require extra visits to your doctor.